Post-acute sequelae of severe acute respiratory coronavirus 2 (SARS-CoV-2) infection continue to affect millions worldwide. Cognitive impairment and fatigue are among the most common lingering symptoms, with cognitive impairment impacting 70% of patients. The ongoing effects of COVID-19 are particularly pronounced in older adults, especially women, who face heightened vulnerability due to factors such as menopause and the resulting increase in cognitive challenges.

Dr. Monica Christmas, associate medical director for The Menopause Society, commented on the findings, noting, “As the authors highlight, post-acute sequelae of severe acute respiratory coronavirus 2 infection significantly affects quality of life, often leading to severe disability. This effect is particularly pronounced in women, who already experience higher rates of cognitive impairment after menopause.” By identifying early risk factors like white blood cell count, healthcare providers could better address the long-term challenges COVID-19 poses, especially for these at-risk groups.

The study, based on secondary analysis from the Women’s Health Initiative, sought to understand whether preexisting risk factors could predict more severe outcomes for older, postmenopausal women. Researchers found that leukocyte count, a common clinical marker of systemic inflammation, was significantly associated with the severity of COVID-19 symptoms.

This breakthrough supports the hypothesis that low-grade inflammation, signaled by white blood cell levels, might not only be an outcome of severe COVID-19 infection but could also serve as an early indicator of who might face more significant illness. The study’s results provide promising evidence that monitoring leukocyte count could offer a cost-effective and easily accessible way to identify those at risk.

While the study’s results are compelling, the researchers emphasize the need for further investigation into the relationship between leukocyte count and COVID-19 outcomes. Nevertheless, this study offers hope for better management and treatment of COVID-19, particularly for the vulnerable populations most impacted by the disease’s lingering effects.

As researchers continue to explore the long-term consequences of COVID-19, understanding the role of systemic inflammation could play a crucial part in mitigating the pandemic’s ongoing health effects.

The post White Blood Cell Count: A Key Predictor of COVID-19 Severity, Study Finds appeared first on FolksTimes.